Dr. Jamal Lewis’s lab is trying to repurpose a fungus to shuttle pharmaceuticals to the central nervous system and treat ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

Title: Randomized, Double-Blind Study of BNC210, a Negative Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor, in Posttraumatic Stress Disorder (PTSD): The Attune Trial Presenter: Murray ...

Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

Terrace Healthcare Center in Bronx, NY, is now providing Viagra as part of its nursing care services to support elderly residents with age-related erectile dysfunction. This initiative aims to improve ...

Bionomics Shareholders should carefully read the Scheme Booklet in its entirety before deciding on how to vote on the Scheme. The Scheme Meeting will be held at 8:30 am Sydney time on Thursday 12 ...

We think UCB is in good financial health, with solid earnings and cash flow generation. UCB has deleveraged over the years, and it ended 2023 with about EUR 2.2 billion in net debt on its balance ...

The complexity of the central nervous system (CNS) and its pathologies necessitates an intricate understanding of the cellular and molecular mechanisms at play. Single-cell biology has emerged as a ...

The autonomic nervous system orchestrates the functions of internal organs such as the heart and gut, serving as a connection ...

Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a Denmark-based clinical-stage biopharmaceutical company, to develop and commercialize ...